Susquehanna International Group’s Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share SBII.WS Stock Holding History
Bought
Maintained
Sold
Susquehanna International Group's SBII.WS Position: Q4 2022 in Review
Susquehanna International Group sold out of Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (SBII.WS) in Q4 2022, closing a stake of 15,390 shares.
Susquehanna International Group first reported a position in SBII.WS in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold SBII.WS as of Q4 2022.
- Susquehanna International Group reported no remaining Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Susquehanna International Group sold 15,390 Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q4 2022.
- Susquehanna International Group first reported a position in Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q3 2022 and held it in 1 quarter.
- Susquehanna International Group's Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $0 in Q3 2022.
- 0 funds tracked by Wall St. Rank held Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.